Re-evaluation Decision Document: Zinc Phosphide

28 June 2007
ISBN: 978-0-662-46335-1 (978-0-662-46336-8)
Catalogue Number: H113-28/2007-1E (H113-28/2007-1E-PDF)
(RVD2007-01)

To obtain an electronic copy of the document, Re-evaluation Decision Document: Zinc Phosphide, please contact publications@hc-sc.gc.ca.

Should you require further information please contact the Pest Management Information Service.

Summary

After a re-evaluation of the rodenticide zinc phosphide, Health Canada's Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is granting continued registration of zinc phosphide products for the sale and use in Canada.

An evaluation of available scientific information found that, under proposed conditions of use, products containing zinc phosphide, do not present unacceptable risks to human health or the environment. As a condition of the continued registration of zinc phosphide uses, new risk-reduction measures must be on the labels of products containing zinc phosphide.

The regulatory approach regarding the re-evaluation of zinc phosphide was first proposed in the consultation document¹: Re-evaluation of Zinc Phosphide (PACR2006-08). This Re-evaluation Decision Document² describes this stage of PMRA's regulatory process concerning the re-evaluation of zinc phosphide and summarizes the Agency's decision and the reasons for it. No comments were received during the consultation process. This decision is consistent with the proposed re-evaluation decision stated in PACR2006-08. To comply with this decision, registrants of products containing zinc phosphide will be informed of the specific requirements affecting their product registration(s) and of regulatory options available to them.

¹ "Consultation statement" as required by subsection 28(2) of the Pest Control Products Act.

² "Decision statement" as required by subsection 28(5) of the Pest Control Products Act.